Abstract
Elevated levels of anti-cardiolipin antibodiesare associated with an increased risk for venous andarterial thrombosis. In patients with inflammatory boweldisease thrombosis is a well known complication. We determined the prevalence of elevatedanti-cardiolipin antibodies in 136 patients withinflammatory bowel disease compared with 136 healthycontrols and analyzed thromboembolic complications inpatients with increased anti-cardiolipin antibodylevels. Anti-cardiolipin antibody titers weresignificantly elevated in patients with Crohn's disease(5.7 units/ml) and ulcerative colitis (5.3 units/ml)compared to the control group (2.5 units/ml). We foundno correlation between disease activity andanti-cardiolipin antibody levels. Seven patients haddeep venous thrombosis in their history, in three ofthem this was complicated by pulmonary embolism. In onlytwo of the seven patients with deep venous thrombosiswere anti-cardiolipin antibody levels increased. Inconclusion, anti-cardiolipin antibody titers were significantly increased in patients withinflammatory bowel disease. Elevated anti-cardiolipinantibody levels appear to play no role in thepathogenesis of thromboembolic events in patients withinflammatory bowel disease.
Similar content being viewed by others
REFERENCES
Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP, Pounder RE: Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 36:1147-1150, 1991
Wakefield AJ, Dhillon AP, Rowles PM, Sawyerr AM, Pittilo RM, Rowles PM, Lewis AAM: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2:1057-1062, 1989
Eber B, Schumacher M, Auer-Grumbach P, Toplak H, Klein W: Increased anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 69:1255-1258, 1992
Love PE, Santoro SA: Anticardiolipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682-698, 1990
Mackworth-Young C: Antiphospholipid antibodies: More than just a disease marker? Immunol Today 11:60-65, 1990
Wiethölter H: Anticardiolipid-Syndrom. Dtsch Med Wochenschr 117:194-196, 1992
Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin antibody test. Clin Exp Immunol 68:215-222, 1987
Harris EN: Annotation: Anticardiolipid antibodies. Br J Haematol 74:1-9, 1990
Harris EN: Reassessment of the anticardiolipid syndrome. J Rheumatol 17:733-735, 1990
Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997-1002, 1992
Koenigs KP, McPhedran P, Spiro HM: Thrombosis in inflammatory bowel disease. J Clin Gastroenterol 9:627-631, 1987
Talbot RW, Heppel J, Dozois RR, Beart RW: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140-145, 1986
Vianna JL, D'Cruz DP, Khamashta MA, Asherson RA, Hughes GRV: Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol 10:165-168, 1992
Papi C, Ciaco A, Acierno G, Di Battista G, Figa Talamanca L, Lo Russo F, Natali G, Capurso L: Antiphospholipid antibodies in a patient with severe ulcerative colitis and cerebraldural sinus thrombosis. Ital J Gastroenterol 25(suppl 1):136, 1993
Mevorach D, Goldberg Y, Gomori JM, Rachmilewitz D: Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. J Clin Gastroenterol 22:141-143, 1996
Milandre I, Monges D, Dor V, Juhan-Vague I, Khalil R: Cerebral phlebitis and Crohn disease. Rev Neurol Paris 148:139-144, 1992
Papi C, Ciaco A, Acierno G, Di-Battista G, Talamanca LF, Lo-Russo F, Natali G, Capruso L: Severe ulcerative colitis, dural sinus thrombosis, and the lupus anticoagulant. Am J Gastroenterol 90:1514-1517, 1995
Silburn PA, Sandstrom PA, Staples C, Mowat P, Boyle RS: Deep cerebral venous thrombosis presenting as an encephalic illness. Postgrad Med J 72:355-368, 1996
Greenfield SM, Teare JP, Whitehead MW, Thompson RP: Amaurosis fugax, Crohn's disease and the anticardiolipin antibody. Lupus 2:271-273, 1993
Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol 24( suppl 170:2-6, 1989
Best WR, Becktel JM, Singleton JW: Rederived value s of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 77:843-846, 1979
Truelove SC, Witts LJ: Cortisone in ulcerative colitis. BMJ 1:1041-1048, 1955
Fox E, Kuo J, Tilling L, Ulrich C: Sigma Stat User's Manual. San Rafael, California, Jandel Scientific, 1994
Bargen JA, Barker NW: Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58:17-31, 1986
Lake AM, Stauffer JQ, Stuatz MJ: Hemostatic alterations in inflammatory bowel disease: Response to therapy. Am J Dig Dis 23:897-902, 1978
Lee JCL, Spittel JA, Sauer WG, Owen ACA, Thompson JH: Hype rcoagulability associated with chronic ulcerative colitis: Changes in blood coagulation factors. Gastroenterology 54:76-85, 1968
Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245-251, 1975
Braverman D, Bogoch A: Arterial thrombosis in ulcerative colitis. Am J Dig Dis 23:1148-1150, 1978
Aadland E, Ødegaard OR, Rø seth A, Try K: Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 27:957-960, 1992
Talstad I, Rootwelt K, Gjone E: Thrombocytosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 8:135-138, 1973
Morowitz DA, Allen LW, Kirsner JB: Thrombocytosis in chronic inflammatory bowel disease. Ann Int Med 68:1013-1021, 1968
Vecchi M, Cattaneo M, de-Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 21:165-170, 1991
Chamouard P, Grunebaum L, Wiesel ML, Freyssinet JM, Duclos B, Cazenave JP, Baumann R: Prevalence and significance of anticardiolipin antibodies in Crohn' s disease. Dig Dis Sci 39:1501-1504, 1994
Chiarantini E, Valanzano R, Liotta AA, Cellai AP, Fedi S, Ilari I, Prisco D, Tonelli F, Abbate R: Hemostatic abnormalities in inflammatory bowel disease. Thromb Res 82:137-146, 1996
Stevens TRJ, Harley SL, Groom JS, Cambridge G, Leaker B, Blake DR, Rampton DS: Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 38:426-432, 1993
Patel RT, Pall AA, Stokes R, Birch D, Hail C, Adu D, Keigley MRB: Autoantibody prevalence and association in inflammatory bowel disease. Eur J Gastroenterol Hepatol 6:705-709, 1994
Rights and permissions
About this article
Cite this article
Aichbichler, B.W., Petritsch, W., Reicht, G.A. et al. Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease. Dig Dis Sci 44, 852–856 (1999). https://doi.org/10.1023/A:1026646816672
Issue Date:
DOI: https://doi.org/10.1023/A:1026646816672